Congo approves use of Ebola vaccination to fight outbreak
The rVSV-ZEBOV vaccine developed by Merck is not yet licensed but was shown to be highly protective against Ebola in clinical trials
By Aaron Ross
KINSHASA, May 29 (Reuters) - Democratic Republic of Congo's health ministry has approved the use of a new Ebola vaccine to counter an outbreak in its northeast that has killed four people, a spokesman said on Monday.
Read more on Thomson Reuters Foundation.
For more humanitarian news and analysis, please visit www.trust.org/alertnet